BriaCell Therapeutics (BCTX) Receivables - Net (2019 - 2026)
BriaCell Therapeutics (BCTX) reported Receivables - Net of $2.59 million for fiscal Q3 2026 (quarter ended Apr 30, 2026), up 11.3% from $2.32 million a year earlier and up 13.8% from the prior quarter.
Powered by 
Analysis
BriaCell Therapeutics (BCTX) Receivables - Net (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Jul 31, 2025), BriaCell Therapeutics posted Receivables - Net of $2.06 million, down 26.2% from FY2024.
- Receivables - Net has a five-year compound annual growth rate of 146.8% (FY2020 to FY2025).
- By fiscal year, Receivables - Net came in at $2.79 million in FY2024 (-51.0%), $5.7 million in FY2023, $24,103 in FY2022 (+91.7%) and $12,574 in FY2021 (-44.2%).
- The fiscal Q3 2026 figure ranks as the highest quarterly Receivables - Net since fiscal Q4 2024.
- Year over year, Receivables - Net gained in two of the last five quarters, with an average decline of 22.3%.
- The high point for year-over-year Receivables - Net in five years was fiscal Q2 2024 (growth of 237.6%); the low point was fiscal Q2 2023 (a decline of 67.1%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $2.28 million (Q2 2026), $1.17 million (Q1 2026) and $2.06 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | BriaCell Therapeutics | 30.16 Mn | 29.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 2.59 Mn |
| Jan 31, 2026 | 2.28 Mn |
| Oct 31, 2025 | 1.17 Mn |
| Jul 31, 2025 | 2.06 Mn |
| Apr 30, 2025 | 2.32 Mn |
| Jan 31, 2025 | 2.15 Mn |
| Oct 31, 2024 | 2.43 Mn |
| Jul 31, 2024 | 2.79 Mn |
| Apr 30, 2024 | 15,233.00 |
| Jan 31, 2024 | 30,145.00 |
| Oct 31, 2023 | 21,410.00 |
| Jul 31, 2023 | 5.70 Mn |
| Apr 30, 2023 | 14,896.00 |
| Jan 31, 2023 | 8,928.00 |
| Oct 31, 2022 | 29,698.00 |
| Jul 31, 2022 | 24,103.00 |
| Apr 30, 2022 | 14,532.00 |
| Jan 31, 2022 | 27,166.00 |
| Jul 31, 2021 | 12,574.00 |
| Jul 31, 2020 | 20,228.96 |
API Access
BriaCell Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=BCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "BCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=BCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();